Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs)- Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Microcarrier market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 4.8 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 9.8% during the prediction period 2021 to 2027. Increasing R&D funding by pharmaceutical and biotechnology companies and shift from use of stainless-steel bioreactors to single-use bioreactors are the key factors supporting the growth of the market.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Microcarrier market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Microcarrier market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

The demand for monoclonal antibodies is growing globally due to the increasing popularity of targeted treatment options for indications such as oncology and autoimmune & inflammatory disorders. As antibodies are administered in high doses, the demand for mAbs is equally high. As of December 2020, the FDA approved 16 monoclonal antibody drugs globally compared to 10 approvals in 2017. Out of these, the majority of the drugs were indicated for cancer and immune diseases.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Microcarrier market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

North America accounted for the largest share of the microcarriers market in 2020.

In 2020, North America accounted for the largest share of the microcarriers market, followed by Europe. The large share of the North American regional segment can be attributed to rising R&D into biologics and gene therapies, technological advancements, and investments in cell-based research.  

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Microcarrier Market are:

The major market players include including Thermo Fisher Scientific (US), Sartorius AG (Germany), Danaher Corporation (US), Corning (US), Eppendorf AG (Germany), BD (US), Merck (Germany), ChemoMetec (Denmark), CESCO Bioengineering (Taiwan), HiMedia Laboratories (India), among others.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

BY PRODUCT

• Consumables
• Media
• Sera/Serum-based Media
• Serum-free Media
• Other Media
• Reagents
• Microcarriers
• Collagen-coated Microcarriers
• Cationic Microcarriers
• Protein-coated Microcarriers
• Untreated Microcarriers
• Other Microcarriers
• Equipment
• Bioreactors
• Single-use Bioreactors
• Stainless-steel Bioreactors
• Culture Vessels  
• Filtration and Separation Equipment
• Cell Counters
• Other Equipment

BY APPLICATION

• Biopharmaceutical Production
• Vaccine Production
• Therapeutic Protein Production
• Cell and Gene Therapy
• Tissue Engineering and Regenerative Medicine
• Other Applications

BY END USER

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations & Contract Manufacturing Organizations
• Academic and Research Institutes
• Cell Banks

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa